Market cap
₹142 Cr
Revenue (TTM)
₹107 Cr
P/E Ratio
28.4
P/B Ratio
--
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | -- | -- | -- |
| EBIT | -- | -- | -- | -- | -- |
| Net Profit | -- | -- | -- | -- | -- |
| EPS | -- | -- | -- | -- | -- |
| Book Value | -- | -- | -- | -- | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | Mar-25 | Mar-24 | Mar-23 |
| EBIT-Margin
| -- | -- | 7.40 | -- | -- |
| Net Margin
| -- | -- | 4.46 | -- | -- |
| Return on equity
| -- | -- | 14.91 | -- | -- |
| Return on Capital
| -- | -- | 16.08 | -- | -- |
| Return on Assets
| -- | -- | 8.40 | -- | -- |
| Debt to Equity (x)
| -- | -- | 0.68 | -- | -- |
Profitability
ROCE
16.08
Higher than Peers by 12.25
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
VijayPD Ceutical
|
16.08
|
--
|
--
|
--
|
--
|
|
Peer Median
|
3.84
|
5.02
|
9.20
|
11.47
|
--
|
ROE
14.91
Higher than Peers by 9.83
Profit after tax / Average Net worth * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
VijayPD Ceutical
|
14.91
|
--
|
--
|
--
|
--
|
|
Peer Median
|
5.08
|
1.59
|
9.09
|
3.59
|
--
|
ROA
8.40
Higher than Peers by 6.21
Profit after tax / Average Total assets * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
VijayPD Ceutical
|
8.40
|
--
|
--
|
--
|
--
|
|
Peer Median
|
2.19
|
1.46
|
2.77
|
1.32
|
--
|
EBIT Margin
7.40
Higher than Peers by 4.46
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
VijayPD Ceutical
|
7.40
|
--
|
--
|
--
|
--
|
|
Peer Median
|
2.93
|
3.78
|
4.14
|
-0.17
|
--
|
Net Margin
4.46
Higher than Peers by 2.49
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
VijayPD Ceutical
|
4.46
|
--
|
--
|
--
|
--
|
|
Peer Median
|
1.96
|
3.27
|
13.99
|
1.55
|
--
|
Cash Profit Margin
5.14
Higher than Peers by 5.14
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
VijayPD Ceutical
|
5.14
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.00
|
0.00
|
0.00
|
0.00
|
--
|
Revenue Growth
--
--
Year on year growth in net sales
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
VijayPD Ceutical
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
50.75
|
56.32
|
1,43,500.00
|
12.18
|
--
|
Net Profit Growth
--
--
Year on year growth in profit after tax
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
VijayPD Ceutical
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
39.96
|
-8.68
|
-48.33
|
-3.70
|
--
|
EPS Growth
--
--
Year on year growth in earnings per share
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
VijayPD Ceutical
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
-21.00
|
--
|
--
|
-3.70
|
--
|
Book Value Growth
--
--
Year on year growth in book value per share
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
VijayPD Ceutical
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
0.68
--
Total debt / Net worth
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
VijayPD Ceutical
|
0.68
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
0.63
|
--
|
--
|
--
|
Short term debt to equity ratio
0.64
--
(Short term borrowings / Net worth)
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
VijayPD Ceutical
|
0.64
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
1.90
Lower than Peers by 0.57
Current Assets / Current Liabilities and Provisions
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
VijayPD Ceutical
|
1.90
|
--
|
--
|
--
|
--
|
|
Peer Median
|
2.47
|
2.33
|
5.05
|
5.68
|
--
|
Quick Ratio
1.43
Lower than Peers by 0.25
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
VijayPD Ceutical
|
1.43
|
--
|
--
|
--
|
--
|
|
Peer Median
|
1.68
|
10.32
|
6.03
|
5.55
|
--
|
Interest Coverage
4.03
Higher than Peers by 1.37
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
VijayPD Ceutical
|
4.03
|
--
|
--
|
--
|
--
|
|
Peer Median
|
2.66
|
2.65
|
2.05
|
5.69
|
--
|
Operating Efficiency
Debtors to sales
22.28
Higher than Peers by 6.91
Debtors outstanding / Net Sales * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
VijayPD Ceutical
|
22.28
|
--
|
--
|
--
|
--
|
|
Peer Median
|
15.37
|
42.99
|
49.21
|
11.90
|
--
|
Asset Turnover
1.87
Higher than Peers by 0.36
Sales / Average Total Assets
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
VijayPD Ceutical
|
1.87
|
--
|
--
|
--
|
--
|
|
Peer Median
|
1.51
|
1.33
|
0.50
|
1.10
|
--
|
Receivable days
81.32
--
Average Debtors / Sales * 365
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
VijayPD Ceutical
|
81.32
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
39.42
--
Average Inventory / Sales * 365
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
VijayPD Ceutical
|
39.42
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
8.63
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
VijayPD Ceutical
|
8.63
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
112.12
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
VijayPD Ceutical
|
112.12
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
--
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
VijayPD Ceutical
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
65.30
|
159.13
|
107.97
|
115.95
|
--
|
Price / Book Value
--
--
Current share price divided by book value per share in the latest financial year
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
VijayPD Ceutical
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
2.35
|
3.26
|
2.54
|
2.60
|
--
|
EV/EBITDA
3.49
Lower than Peers by 49.86
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
VijayPD Ceutical
|
3.49
|
--
|
--
|
--
|
--
|
|
Peer Median
|
53.35
|
29.43
|
2.43
|
179.61
|
--
|
Market Cap
--
--
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
VijayPD Ceutical
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
30
|
20
|
13
|
13
|
--
|